38093-76-4 Usage
Description
2-methyl-4-phenylthiazol-5-Amine is a chemical compound that belongs to the thiazole class of organic compounds. It is a derivative of thiazole, which is a five-membered heterocyclic ring containing one sulfur and one nitrogen atom. 2-methyl-4-phenylthiazol-5-Amine can be synthesized through various chemical reactions and is known for its potential biological activities, including anti-inflammatory and antioxidant properties. Its structure and reactivity also make it a valuable building block in the synthesis of complex organic molecules. Overall, 2-methyl-4-phenylthiazol-5-Amine is a versatile chemical compound with potential applications in pharmaceutical and organic synthesis.
Uses
Used in Pharmaceutical Industry:
2-methyl-4-phenylthiazol-5-Amine is used as a key intermediate in the development of new pharmaceutical drugs due to its unique structure and reactivity. Its potential biological activities, such as anti-inflammatory and antioxidant properties, make it a promising candidate for the treatment of various diseases and conditions.
Used in Organic Synthesis:
2-methyl-4-phenylthiazol-5-Amine is used as a valuable building block in the synthesis of complex organic molecules. Its unique structure and reactivity allow for the creation of a wide range of compounds with diverse applications in various industries, including pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 38093-76-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,0,9 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 38093-76:
(7*3)+(6*8)+(5*0)+(4*9)+(3*3)+(2*7)+(1*6)=134
134 % 10 = 4
So 38093-76-4 is a valid CAS Registry Number.
38093-76-4Relevant articles and documents
THIAZOLYL AND OXAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
-
Paragraph 00516, (2014/06/11)
Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.
Versatile assembly of 5-aminothiazoles based on the Ugi four-component coupling
Thompson, Mark J.,Chen, Beining
, p. 5324 - 5327 (2008/12/22)
A flexible route to novel 5-aminothiazoles has been developed based on cyclisation of diamide adducts, prepared using the Ugi reaction, in the presence of Lawesson's reagent. The Walborsky reagent (1,1,3,3-tetramethylbutyl isocyanide) was used as the isonitrile component, facilitating subsequent deprotection of the N-alkyl group to yield free 5-aminothiazoles, which were prepared with a variety of substituents at the 2- and 4-positions.
THIAZOLE DERIVATIVES, THEIR PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPY
-
Page/Page column 35, (2008/06/13)
The invention provides compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein A, R1, R2 and R3 are as defined in the specification; a process for their preparation; pharmaceutical compositions con